Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Topotecan (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 27 Jul 2010 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
- 27 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.